BROLUCIZUMAB-DBLL for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 583 adverse event reports in the FDA FAERS database where BROLUCIZUMAB-DBLL was used for Product used for unknown indication.
Most Reported Side Effects for BROLUCIZUMAB-DBLL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Vitreous floaters | 479 | 17.1% | 4 | 18 |
| Visual impairment | 446 | 15.9% | 1 | 28 |
| Vision blurred | 416 | 14.9% | 2 | 15 |
| Eye inflammation | 387 | 13.8% | 2 | 10 |
| Visual acuity reduced | 365 | 13.0% | 1 | 19 |
| Retinal vasculitis | 323 | 11.5% | 3 | 22 |
| Uveitis | 305 | 10.9% | 1 | 16 |
| Vitritis | 284 | 10.1% | 2 | 19 |
| Eye pain | 234 | 8.4% | 0 | 18 |
| Vitreous opacities | 205 | 7.3% | 1 | 15 |
| Anterior chamber cell | 199 | 7.1% | 2 | 15 |
| Blindness | 191 | 6.8% | 3 | 20 |
| Keratic precipitates | 183 | 6.5% | 1 | 8 |
| Death | 178 | 6.4% | 177 | 2 |
| Drug ineffective | 170 | 6.1% | 0 | 5 |
Other Indications for BROLUCIZUMAB-DBLL
Neovascular age-related macular degeneration (1,535)
Age-related macular degeneration (445)
Choroidal neovascularisation (104)
Polypoidal choroidal vasculopathy (64)
Diabetic retinal oedema (60)
Macular degeneration (51)
Retinal vein occlusion (15)
Detachment of retinal pigment epithelium (8)
Diabetic retinopathy (7)
Retinal neovascularisation (7)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)